Login / Signup

Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.

Thomas C BoothTimothy J LarkinYinyin YuanMikko I KettunenSarah N DawsonDaniel ScoffingsHolly C CanutoSarah L VowlerHeide KirschenlohrMichael P HobsonFlorian MarkowetzSarah JefferiesKevin M Brindle
Published in: PloS one (2017)
Analysis of heterogeneity, in T2-weighted MR images, which are acquired routinely in the clinic, has the potential to detect an earlier treatment response allowing an early change in treatment strategy. Prospective validation of this technique in larger datasets is required.
Keyphrases